Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Exchange Rate Effect (2018 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Exchange Rate Effect for 5 consecutive years, with -$590000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 61.89% to -$590000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, up 301.54% year-over-year, with the annual reading at $2.4 million for FY2025, 301.54% up from the prior year.
  • Exchange Rate Effect hit -$590000.0 in Q4 2025 for Ligand Pharmaceuticals, down from -$400000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $5.2 million in Q3 2024 to a low of -$4.8 million in Q2 2024.